BL 322 (Relhist DMX dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg)
Generic Name: dextromethorphan/guaifenesin/phenylephrine
Pill with imprint BL 322 is Yellow, Elliptical / Oval and has been identified as Relhist DMX dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg. It is supplied by Burel Pharmaceuticals, Inc..
Relhist DMX is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Relhist DMX dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BL 322
- Generic Name
- BL 322
- dextromethorphan hydrobromide 15 mg / guaifenesin 380 mg / phenylephrine hydrochloride 10 mg
- 16.00 mm
- Elliptical / Oval
- Rx and/or OTC
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC)
- Inactive Ingredients
D&C Yellow No. 10, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A corn
Note: Inactive ingredients may vary.
More about Relhist DMX (dextromethorphan / guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Drug class: upper respiratory combinations
- FDA Alerts (3)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.